These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 37658461)

  • 1. Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients.
    Al-Jumaan M; Chu H; Alsulaiman A; Camp SY; Han S; Gillani R; Al Marzooq Y; Almulhim F; Vatte C; Al Nemer A; Almuhanna A; Van Allen EM; Al-Ali A; AlDubayan SH
    Genome Med; 2023 Sep; 15(1):65. PubMed ID: 37658461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polygenic risk scores for the prediction of common cancers in East Asians: A population-based prospective cohort study.
    Ho PJ; Tan IB; Chong DQ; Khor CC; Yuan JM; Koh WP; Dorajoo R; Li J
    Elife; 2023 Mar; 12():. PubMed ID: 36971353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Profiling of pharmacogenomic variants in
    Alsulaiman A; Chu H; Al-Jumaan M; Alyahya M; Marzooq YA; Almulhim F; Vatte C; Alnimer A; Almuhanna A; Al-Ali A; AlDubayan SH
    Pharmacogenomics; 2023 May; 24(7):411-423. PubMed ID: 37222147
    [No Abstract]   [Full Text] [Related]  

  • 4. Accurate genome-wide genotyping from archival tissue to explore the contribution of common genetic variants to pre-cancer outcomes.
    Nachmanson D; Pagadala M; Steward J; Cheung C; Bruce LK; Lee NQ; O'Keefe TJ; Lin GY; Hasteh F; Morris GP; Carter H; Harismendy O
    J Transl Med; 2022 Dec; 20(1):623. PubMed ID: 36575447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The yield of full BRCA1/2 genotyping in Israeli Arab high-risk breast/ovarian cancer patients.
    Bernstein-Molho R; Barnes-Kedar I; Ludman MD; Reznik G; Feldman HB; Samra NN; Eilat A; Peretz T; Peretz LP; Shapira T; Magal N; Kalis ML; Yerushalmi R; Vinkler C; Liberman S; Basel-Salmon L; Shohat M; Levy-Lahad E; Friedman E; Bazak L; Goldberg Y
    Breast Cancer Res Treat; 2019 Nov; 178(1):231-237. PubMed ID: 31368036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Individuals with common diseases but with a low polygenic risk score could be prioritized for rare variant screening.
    Lu T; Zhou S; Wu H; Forgetta V; Greenwood CMT; Richards JB
    Genet Med; 2021 Mar; 23(3):508-515. PubMed ID: 33110269
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of polygenic risk and susceptibility genes in breast cancer over the course of life.
    Mars N; Widén E; Kerminen S; Meretoja T; Pirinen M; Della Briotta Parolo P; Palta P; ; Palotie A; Kaprio J; Joensuu H; Daly M; Ripatti S
    Nat Commun; 2020 Dec; 11(1):6383. PubMed ID: 33318493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Common Genetic Variants With Contralateral Breast Cancer Risk in the WECARE Study.
    Robson ME; Reiner AS; Brooks JD; Concannon PJ; John EM; Mellemkjaer L; Bernstein L; Malone KE; Knight JA; Lynch CF; Woods M; Liang X; Haile RW; Duggan DJ; Shore RE; Smith SA; Thomas DC; Stram DO; Bernstein JL;
    J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 28521362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluating the prognostic performance of a polygenic risk score for breast cancer risk stratification.
    Olsen M; Fischer K; Bossuyt PM; Goetghebeur E
    BMC Cancer; 2021 Dec; 21(1):1351. PubMed ID: 34930164
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Polygenic risk scores indicate extreme ages at onset of breast cancer in female BRCA1/2 pathogenic variant carriers.
    Borde J; Laitman Y; Blümcke B; Niederacher D; Weber-Lassalle K; Sutter C; Rump A; Arnold N; Wang-Gohrke S; Horváth J; Gehrig A; Schmidt G; Dutrannoy V; Ramser J; Hentschel J; Meindl A; Schroeder C; Wappenschmidt B; Engel C; Kuchenbaecker K; Schmutzler RK; Friedman E; Hahnen E; Ernst C
    BMC Cancer; 2022 Jun; 22(1):706. PubMed ID: 35761208
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A role for common genomic variants in the assessment of familial breast cancer.
    Sawyer S; Mitchell G; McKinley J; Chenevix-Trench G; Beesley J; Chen XQ; Bowtell D; Trainer AH; Harris M; Lindeman GJ; James PA
    J Clin Oncol; 2012 Dec; 30(35):4330-6. PubMed ID: 23109704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent TP53 missense mutation in cancer patients of Arab descent.
    Zick A; Kadouri L; Cohen S; Frohlinger M; Hamburger T; Zvi N; Plaser M; Avital E; Breuier S; Elian F; Salah A; Goldberg Y; Peretz T
    Fam Cancer; 2017 Apr; 16(2):295-301. PubMed ID: 27866339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low coverage whole genome sequencing enables accurate assessment of common variants and calculation of genome-wide polygenic scores.
    Homburger JR; Neben CL; Mishne G; Zhou AY; Kathiresan S; Khera AV
    Genome Med; 2019 Nov; 11(1):74. PubMed ID: 31771638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and Validation of a Breast Cancer Polygenic Risk Score on the Basis of Genetic Ancestry Composition.
    Hughes E; Wagner S; Pruss D; Bernhisel R; Probst B; Abkevich V; Simmons T; Hullinger B; Judkins T; Rosenthal E; Roa B; Domchek SM; Eng C; Garber J; Gary M; Klemp J; Mukherjee S; Offit K; Olopade OI; Vijai J; Weitzel JN; Whitworth P; Yehia L; Gordon O; Pederson H; Kurian A; Slavin TP; Gutin A; Lanchbury JS
    JCO Precis Oncol; 2022 Nov; 6():e2200084. PubMed ID: 36331239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polygenic risk score is associated with increased disease risk in 52 Finnish breast cancer families.
    Muranen TA; Mavaddat N; Khan S; Fagerholm R; Pelttari L; Lee A; Aittomäki K; Blomqvist C; Easton DF; Nevanlinna H
    Breast Cancer Res Treat; 2016 Aug; 158(3):463-9. PubMed ID: 27438779
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polygenic risk scores and risk stratification in deep vein thrombosis.
    Lo Faro V; Johansson T; Höglund J; Hadizadeh F; Johansson Å
    Thromb Res; 2023 Aug; 228():151-162. PubMed ID: 37331118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition to cancer across people of different ancestries in Qatar: a population-based, cohort study.
    Saad M; Mokrab Y; Halabi N; Shan J; Razali R; Kunji K; Syed N; Temanni R; Subramanian M; Ceccarelli M; ; Rafii Tabrizi A; Bedognetti D; Chouchane L
    Lancet Oncol; 2022 Mar; 23(3):341-352. PubMed ID: 35150601
    [TBL] [Abstract][Full Text] [Related]  

  • 18. An investigation of the association of genetic susceptibility risk with somatic mutation burden in breast cancer.
    Zhu B; Mukherjee A; Machiela MJ; Song L; Hua X; Shi J; Garcia-Closas M; Chanock SJ; Chatterjee N
    Br J Cancer; 2016 Sep; 115(6):752-60. PubMed ID: 27467053
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined Effect of a Polygenic Risk Score and Rare Genetic Variants on Prostate Cancer Risk.
    Darst BF; Sheng X; Eeles RA; Kote-Jarai Z; Conti DV; Haiman CA
    Eur Urol; 2021 Aug; 80(2):134-138. PubMed ID: 33941403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polygenic risk score (PRS) and its potential for breast cancer risk stratification.
    Hovhannisyan M; Kleiblová P; Nehasil P; Soukupová J; Zemánková P; Kleibl Z; Janatová M
    Klin Onkol; 2023; 36(3):198-205. PubMed ID: 37353348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.